HDAC6 and inflammatory skin disease: Bufexamac, an aryl alkanoic acid derivative and a nonsteroidal anti-inflammatory agent for the topical treatment of eczema and other inflammatory skin diseases [56], is a specific inhibitor of the deacetylases of histone types IIB (HDAC6 and HDAC10 [57]).